BeStock  
Stocks › Biotechnology › DYN

Dyne Therapeutics DYN

US equityMarket cap rank #2457Biotechnology
$15.50 −$0.53 (-3.31%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $15.50 0.00%
Open$15.91
Prev close$16.03
Day range$15.41 – $16.48
Volume2.23M
Market cap$2.90B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

DYN at a glance

DYN is priced at $15.50 right now, down 3.31% on the session. That puts its market value at $2.90B, 2457th largest among the 3753 stocks we cover.

It is close to the bottom of its 52-week range ($14.00 to $27.31), 43.2% under the high. Holders are behind 26.8% over twelve months, and down 40.4% across the last three months.

On the chart it has slipped under both the 50-day ($16.55) and 200-day ($19.27) moving averages; RSI is 39, and the last 30 sessions moved at roughly 61% annualized volatility.

Revenue for the quarter ended Sep 2026 was $0.00, and a net loss of $193.55M.

10 analysts follow the stock and the average call is "buy". The mean target, $34.90, sits 125.2% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$15.50 / $17.85
Average price today$15.74
Volume2.23MAvg (90d) 2.80M
Turnover$35.12M
Turnover rate1.19%of shares outstanding
Volume ratio1.02vs. recent average pace
Day amplitude6.68%
Market cap$2.90B
Float market cap$2.90B
Shares outstanding186.86M
EPS (TTM)-$3.47
P/B3.12
Book value / share$4.97
Net profit (TTM)-$650.23M
Net assets$930.94M
30-day volatility61.5%annualized
Avg daily range (ATR)6.35%of price, 14 days
Max drawdown (1y)-46.8%-42.1% from 1y peak

Quote as of Nov 20, 2026 8:20 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

10 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 54.5 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth73.7
Profitability14.3
Momentum14.1
Financial health78.2
Analyst view90.5

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$34.90+125.2% vs. current price
Consensus ratingBuy10 analysts covering
Morningstar fair value$32.07Price is below fair value

Wall Street’s average 12-month target is $34.90, 125.2% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $32.07, so shares trade 51.7% below that estimate. On earnings multiple, it sits in the 38th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-3.3%
1 week
-9.7%
1 month
-1.7%
3 months
-40.4%
6 months
-10.8%
Year to date
-20.8%
1 year
-26.8%
Day range
$15.41$16.48
52-week range
$14.00$27.31

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 7 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-9.2%Bearish
Price vs 50-day average-6.4%Bearish
Price vs 200-day average-19.6%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)39.1Bearish
MACD (12,26,9)-0.25Bearish
Bollinger band position8%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How DYN ranks on BeStock

Market value#2446 of 3734
Closeness to 52-week high#2787 of 3724
Dollar volume today#1658 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

DYN is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on DYN.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on DYN

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

DYN stock: common questions

Where is DYN trading right now?

$15.50 is the latest print for DYN, a move of -3.31% against yesterday's close of $16.03. Today's low and high so far: $15.41 and $16.48.

What is DYN worth in total?

Equity value comes to $2.90B at the current price. By that measure it is number 2457 of the 3753 names in our coverage.

Where does DYN sit in its 52-week range?

The year's floor is $14.00 and the ceiling $27.31. Shares are 43.2% away from that ceiling.

Does DYN send cash back through a dividend?

Our data shows no dividend paid by Dyne Therapeutics over the trailing twelve months.

Do Wall Street analysts like DYN?

Of 10 analysts, 90% say buy, 0% hold and 10% sell. Price targets average $34.90, with the most cautious at $10.00 and the most optimistic at $50.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on DYN.

Sign in to join the discussion.

Scroll to Top